Lunai Bioworks Inc. (LNAI)
NASDAQ: LNAI · Real-Time Price · USD
0.5568
+0.3449 (162.77%)
At close: Mar 17, 2026, 4:00 PM EDT
0.5214
-0.0354 (-6.35%)
After-hours: Mar 17, 2026, 7:59 PM EDT
Lunai Bioworks Market Cap
Lunai Bioworks has a market cap or net worth of $13.47 million as of March 17, 2026. Its market cap has decreased by -90.50% in one year.
Market Cap
13.47M
Enterprise Value
15.73M
1-Year Change
-90.50%
Ranking
Category
Stock Price
$0.56
Market Cap Chart
Since December 11, 2018, Lunai Bioworks's market cap has decreased from $252.00M to $13.47M, a decrease of -94.66%. That is a compound annual growth rate of -33.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 13.50M | -34.78% |
| Dec 31, 2025 | 20.70M | -84.39% |
| Dec 31, 2024 | 132.60M | -37.28% |
| Dec 29, 2023 | 211.40M | 287.89% |
| Dec 30, 2022 | 54.50M | -85.68% |
| Dec 31, 2021 | 380.70M | 176.67% |
| Dec 31, 2020 | 137.60M | -40.77% |
| Dec 31, 2019 | 232.30M | -8.25% |
| Dec 31, 2018 | 253.20M | 0.48% |
| Dec 11, 2018 | 252.00M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Psyence Biomedical | 5.73M |
| XTL Biopharmaceuticals | 5.49M |
| Biodexa Pharmaceuticals | 5.00M |
| Aptorum Group | 4.99M |
| Silexion Therapeutics | 4.91M |
| Creative Medical Technology Holdings | 4.90M |
| Aspire Biopharma Holdings | 4.90M |
| Genprex | 4.80M |